Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
European Urology|July 24, 2003
Argon plasma coagulation (APC) for endo-urological procedures: ex-vivo evaluations of hemostatic propertiesOliver Reich, Peter Schneede, Anwar Mseddi, et al.
Urological Research|April 11, 2002
In vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP), and vaporization-resection of the prostate (TUVRP)Oliver Reich, Stefan Corvin, Ralph Oberneder, et al.
BMC Gastroenterology|December 4, 2017
Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014Caroline Bähler, Stephan R Vavricka, Alain M Schoepfer, et al.
BMC Ophthalmology|December 6, 2017
Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from SwitzerlandOliver Reich, Martin K Schmid, Roland Rapold, et al.
The Journal of Urology|May 6, 2004
Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostateOliver Reich, Alexander Bachmann, Peter Schneede, et al.
Plos One|February 27, 2015
Appropriateness of diagnostic coronary angiography as a measure of cardiac ischemia testing in non-emergency patients - a retrospective cross-sectional analysisCorinne Chmiel, Oliver Reich, Andri Signorell, et al.
International Journal of Public Health|July 17, 2020
Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims dataCaroline Bähler, Roland Rapold, Andri Signorell, et al.
European Urology|February 17, 2006
Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomyBoris Schlenker, Christian Gratzke, Oliver Reich, et al.
The Journal of Urology|December 14, 2004
High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patientsOliver Reich, Alexander Bachmann, Michael Siebels, et al.
European Journal of Gastroenterology & Hepatology|May 15, 2018
Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in SwitzerlandAlain Schoepfer, Stephan R Vavricka, Beat Brüngger, et al.
Pageof 15